A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis
Kevin H.M. Kuo(University Health Network), Hans A. Messner(University of Toronto), Jeffrey H. Lipton(Princess Margaret Cancer Centre), Mark D. Minden(University Health Network), Joseph Brandwein(Goethe University Frankfurt), Aaron D. Schimmer(University of Toronto), Graham D. Sher(Unknown), Armand Keating(University Health Network), Karen Yee(University Health Network), Michael Crump(University of Toronto), Vikas Gupta(Indian Institute of Technology Kanpur), Tony Panzarella(Princess Margaret Cancer Centre), Jeannie Callum(Sunnybrook Health Science Centre), Andre C. Schuh(University of Toronto), John E. Curtis(London Health Sciences Centre), Lindsay M. Jacks(ErinoakKids Centre for Treatment and Development)
Cited by 45
Related Papers
Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma
|JAMA|2015|2.5k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
The genomic landscape of hypodiploid acute lymphoblastic leukemia
|Nature Genetics|2013|737